# Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?

> **NCT02040350** · PHASE1 · COMPLETED · sponsor: **Sheri Kashmir Institute of Medical Sciences** · enrollment: 100 (actual)

## Conditions studied

- Deaths

## Interventions

- **DRUG:** Pralidoxime

## Key facts

- **NCT ID:** NCT02040350
- **Lead sponsor:** Sheri Kashmir Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040350, "Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02040350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*